The company is reportedly looking to expand beyond its stationary fitness equipment and enter into the competitive wearables market.
The virtual behavioral healthcare company is now trading on Nasdaq under the symbol TALK; As part of the deal, it also got $250M of growth capital.
The deal provides additional investment to capitalize on Pear's position by investing in the commercialization of its three FDA-authorized products.
The result of the reorganization is a downsized team along with a streamlined focus on clinical and regulatory work rather than consumer-facing offerings.
It is a four-week technical, business, and mentorship accelerator open to US-based startups or international startups that have existing US operations.
The Chinese University of Hong Kong, ConsenSys announce the Medoxie COVID-19 Digital Health Passport
The Medoxie platform uses ConsenSys Quorum to record all COVID-19 related events in a decentralized, private, and secure manner.
Launched as a joint venture between Sanofi, Capgemini, Generali and Orange - it aims to stimulate the development of e-health solutions.
The FDA issued a letter to the company declaring that it will not accept a letter of intent for the company's Parkinson's exam.
The new device improves access to back health solutions and is aimed at increasing membership on Dario's integrated personalization platform.
The updated software provides athletes with advanced sleep monitoring, additional animated on-screen workouts and more.